ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001080.1|Phenazine_2 # 1009 # 2046 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.698	BGC0001080.1|Phenazine_2 	1009	2046	+	Loose	600	27.7202	Rm3	26.56	3003894	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	Rm3 family beta-lactamase	ATGCAGAAACGACAAGCGGAGCTGAGTGTGTTGATTCCACCGAACTCAGCGAAGGGGTTATCGAAAAGCCACCGGGCTCGCTCGGTCGGCATCGGCCGTGCTCACGCCAAGGCAATTCTGCTGGGCGAACACGCGGTCGTCTACGGAGCTCCGGCGCTCGCTCTTCCGATTCCGCAACTGACCGCCACGGCAAGCGTCGGATGGTCCCCCCACTCCCCCGACGGCCCGCACGACATGTCGCTCACGATGACCGGTTCGGCGTCGAGGCCGATGGTGACGCAAGCCTCCGAGAGCCTGCGGCGGCTCACCGCCGAATTCAGGGCCTCCATGGGTGTGACCGACCGGCTGCACCTCGACATGGTCATCGACTGTGCGATCCCGCCCGGCCGGGGGCTCGGTTCCAGCGCGGCGTGCGCGCGCGCGGTCGTGCTGGCCCTGGCCGATCTCTTCGACCGCGAGATCTCGCAGAGCACCGCCTTCGACCTGGTCCAGACGGCGGAGAACGTGACGCACGGCCGGGCCAGCGGCGTCGACGCCATGGCCGTCGGGGCCTCGGTCCCGCTGCTGTTCCAGGCGGGCGGGGCCCAGGAACTGGCCGTCGGCTGCGAGGGGTTGTTCATCATCGCGGACAGCGGCGTCGTGGGCAGGACCAAGGACGCGGTCGAGCTGTTACGGGAGGGGTTCCTGCGTCATCCCGGATCGCAGGAGAGATTCGTGCGCCGGGCGTCGGTCCTGACCGAGGAGGCCAGGCACGCCTTCGCCGACGGCAGGCCGGAGGAGCTCGGCTCACGGCTCACGGACTACCACGAACTGCTCCGTACGGCAGGCCTCAGCATCGACCGGATCGACACGCTGGTGGAGGCCGCCCGCACCGCCGGCGCTCTCGGAGCCAAGATGACCGGGGGCGGCATGGGCGGCTGCATGATCGCCCTGACCCGGTCGTGGCAGGCGAGCGAGGTCACCCGGAAGCTGCACGAGGCCGGCGCCGTGCAGACGTGGGTGCTGCCGCTGAGGAGGCTCGCCGGCCATGCGCCCTGA	MQKRQAELSVLIPPNSAKGLSKSHRARSVGIGRAHAKAILLGEHAVVYGAPALALPIPQLTATASVGWSPHSPDGPHDMSLTMTGSASRPMVTQASESLRRLTAEFRASMGVTDRLHLDMVIDCAIPPGRGLGSSAACARAVVLALADLFDREISQSTAFDLVQTAENVTHGRASGVDAMAVGASVPLLFQAGGAQELAVGCEGLFIIADSGVVGRTKDAVELLREGFLRHPGSQERFVRRASVLTEEARHAFADGRPEELGSRLTDYHELLRTAGLSIDRIDTLVEAARTAGALGAKMTGGGMGGCMIALTRSWQASEVTRKLHEAGAVQTWVLPLRRLAGHAP	MSLTPPRALVLALLLASPGTQAQTPAPATPPTPGCEVCATWNADQAPFRLFGNTYYVGMKGLSSVLVTSPQGHVLIDGGLPESAPKIIANIGALGFRIEDVKLILNSHGHIDHAGGLAELQRRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGQFNVGPVYLTAHATPGHTPGGLSWTWQSCDGPRCLNMVYADSINAVSRPGFKFSASSEYPNALADLRHSFETLEKLPCDVLISAHPEASQLWQRLEASATGGSDAFVDPQACRAYVAAARTLLDSRLDQEKQQ	114.24	gnl|BL_ORD_ID|4702|hsp_num:0	2375			258	615	
BGC0001080.1|Phenazine_3 # 2036 # 3091 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.737	BGC0001080.1|Phenazine_3 	2036	3091	+	Loose	525	29.6462	LRA-1	35.0	3002482	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class A LRA beta-lactamase	ATGCGCCCTGACCACCCGCACGCTCCGGACCGGAGCCGGGAGCACGGTGCCGCGGGGGGTGCCACCGCCGTCGCGCACCCGAACATCGCGCTGATCAAGTACTGGGGCAAACGGGACGAGCGGCTCGTCCTCCCCCGGACGGACAGCCTGTCGATGACCCTGGACATCCTCCCGACCACCACCCACGTCCGGCTCGACCCCGAGGCGGAACATGACGAGGTGACGCTCGACGGCGTCCCCCTGGAGGGCGGGCCGAGGCAACGCGTCATCACCTTCCTGGAACTGGTGCGGGAGCGGGCGGGCAGCTCCCGGCGCGCTGCCGTCGACTCCCGGAACACCGTTCCCACCGGGGCCGGGCTCGCGTCCTCCGCGAGCGGGTTCGCCGCCCTCGCCGTCGCCGCGTCCGCCGCGTACGGTCTCGGTCTCGACGCGACCGCGCTGTCACGGCTGGCCCGGCGAGGATCGGGATCGGCGTCGCGGTCGATCTTCGGTGACTTCGCGATCTGGCACGCCGGCCGGCCCACCGGATCGGCCACGGACGCGGACCTGGGCTCATACGCCGAACCGGTACCCGCGGCGGAGTTCGACCCCGCCCTGGTCATCGCGGTGGTCAACGCCGGGCCCAAGGACGTGTCCAGCCGGGAGGCCATGCGGCGGACCGTCGAGACCTCGCCGCTGTACGGGCCGTGGGCAGCCTCCAGCGAGGGCGACCTCGTCGACATGCGGGTGGCGTTGCGACGGGGCGATCTCGATGCGGTGGGAGAGATCGCGGAGCGGAACGCGCTCGGCATGCACGCGACGATGCTGGCGGCTCGCCCTGCGGTGCGCTATCTGTCGGCGCCCACGCTCGACGTGCTCGACAGCGTGCTGCGGCTCAGGCGGGACGGGGTCCCGGCCTACGCGACCATGGACGCCGGACCGAACGTCAAGGTGCTCTGCCATCGCACGGACGCGGACCGGGTGGCCCAGGTGGTGCGAAGTGCCGCCCCGGGCGGCTCGGTGCTCGTCGCCGGGCGGGGACCGGGCGCCCGTCTGCTGGCCGAGGGCGAGCGATGA	MRPDHPHAPDRSREHGAAGGATAVAHPNIALIKYWGKRDERLVLPRTDSLSMTLDILPTTTHVRLDPEAEHDEVTLDGVPLEGGPRQRVITFLELVRERAGSSRRAAVDSRNTVPTGAGLASSASGFAALAVAASAAYGLGLDATALSRLARRGSGSASRSIFGDFAIWHAGRPTGSATDADLGSYAEPVPAAEFDPALVIAVVNAGPKDVSSREAMRRTVETSPLYGPWAASSEGDLVDMRVALRRGDLDAVGEIAERNALGMHATMLAARPAVRYLSAPTLDVLDSVLRLRRDGVPAYATMDAGPNVKVLCHRTDADRVAQVVRSAAPGGSVLVAGRGPGARLLAEGER	MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATGARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVATGMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPGDLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKTGSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS	118.98	gnl|BL_ORD_ID|1464|hsp_num:0	1601			264	441	
BGC0001080.1|Phenazine_5 # 4200 # 5291 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0001080.1|Phenazine_5 	4200	5291	+	Loose	1500	27.7202	rphB	33.33	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGATCTCCCAACGCAAGGACGACCACGTCAGGCTCGCCGTCGAACAGCAGCAGGCACTCGACGGAAGGAACCAGTTCGACGAGGTGTCGTTCGTCCACCACGCGCTGGCCGGCATCGACCGGCCGGATGTCTCCCTGGCCACGACGTTCGCCGGCATCGCCTGGCAGGTCCCGCTGTACATCAACGCGATGACCGGCGGCAGCACGCACACCGGCGCCATCAACCGGGACCTGGCCATCGCCGCCCGGGAGACGGGGGTGCCCATCGCGTCGGGATCCATGAGCGCGTACTTCAAGGACCCCTCGTGTGCCGACACGTTCCGCGTGCTGCGCCAGGAGAACCCCGACGGCTTCGTCATGGCGAACATCAACGCGACGGCCTCGGTAGACAAGGCGCGGCGGGCCATCGGCCTCCTGGAGGCCGACGCCCTGCAGATCCACATCAACACGGTGCAGGAGACGGTGATGCCCGAGGGGGACCGGTCGTTCTCCTCCTGGGTCCCGCAGATCGAGAGGATCACGGCGGCCGTCGACGTCCCGGTGATCGTCAAGGAGGTCGGCTTCGGGCTGAGCCGTGAAACCGTCCTGACTCTGCGGAACCTGGGCGTGCGGGTGGCGGACCTCGGCGGCCGGGGCGGCACGGACTTCGCCCGGATCGAGAACGGCAGGAGGGAGCTCGCCGACTACGCGTACCTCCACGGCTGGGGACTGTCCACCGCCGCCTGTCTCCTGGACGCGCGGGACCCCGGGATCCCCGTGCTCGCCTCCGGAGGCGTCCGCCACCCGCTCGACGTCGTACGCGCGCTGGCGCTCGGCGCGTCCGGCGTCGGGGTGTCCGGGGGGTTCCTCCGCACGCTGATGGACGGCGGTGTCACCGCACTGGTCGCGCAGATCTCGACCTGGCTCGACCAACTGGGAGCCCTGCAGACCATGCTCGGCTCCCGCACCCCGGCCGGGCTGACGGGATGCGATCTGCAGATCCACGGCACCCTCCGCGACTTCTGCGCCGACCGGGGCATCGACACCGGCCGGCTCGCCCTGCGCTCCAGCTCCTTCGACGCCCTCCACGAGATGACGGGAAGCACTCGATGA	MISQRKDDHVRLAVEQQQALDGRNQFDEVSFVHHALAGIDRPDVSLATTFAGIAWQVPLYINAMTGGSTHTGAINRDLAIAARETGVPIASGSMSAYFKDPSCADTFRVLRQENPDGFVMANINATASVDKARRAIGLLEADALQIHINTVQETVMPEGDRSFSSWVPQIERITAAVDVPVIVKEVGFGLSRETVLTLRNLGVRVADLGGRGGTDFARIENGRRELADYAYLHGWGLSTAACLLDARDPGIPVLASGGVRHPLDVVRALALGASGVGVSGGFLRTLMDGGVTALVAQISTWLDQLGALQTMLGSRTPAGLTGCDLQIHGTLRDFCADRGIDTGRLALRSSSFDALHEMTGSTR	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	41.06	gnl|BL_ORD_ID|2235|hsp_num:0	2528			2436	2583	rifampin; rifaximin; rifabutin; rifapentine
BGC0001080.1|Phenazine_7 # 6353 # 7528 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.709	BGC0001080.1|Phenazine_7 	6353	7528	+	Loose	300	27.7202	poxtA	29.79	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCCGGCGAGACCGCGGTCGGAATCCACGACCTCTCGTTCGCGACGACCGAGTTCGTCCTGCCGCACACGGCACTGGCCGACCACAACGGCACCGACATCGGCAAGTACCACCGGGGCATCGGCCAGCGGTCGATGAGCGTGCCCGCCGCCGACGAGGACATCGTGACCATGGGCGCGGCCGCCGCCGCGCCCATCATCGCCCGGCACGGCTTCGACCGGATCCGGACGGTCGTCCTCGCGACGGAGTCGTCGGTCGACCAGGCGAAGTCGGCCGGTGTGTACGTGCATTCGCTGCTCGGGCTGCCGTCGGCCACCAGGGTCGTCGAGCTGAAGCAGGCCTGTTACGGGGCGACGGCGGCCCTGCAGTTCGCCATCGGCCTCGTGCACCGTGACCCGGCGCAGCAGGTCCTCGTGGTCGCGAGCGACATCTCCAAGTACGAGCTGGACAGCCCGGGCGAGGCGACCCAGGGCGCGGCGGCGGTGGCGATGCTGGTCGGGTCGGACCCGGCTCTGCTGCGCGTCGAGGAGCCGTCGGGCCTGTTCACCGCCGACGTCATGGACTTCTGGCGGCCGAACTACCGCGACGCCGCGCTGGTCGACGGACAGGAGTCGATCACCGCGTATCTGCAGGCGGTGGAGGGCACCTGGAAGGACTACACGGAGCGGGGTGGCCGCGCGCTGGACGCGTTCAGCGCGTTCTGCTATCACCAGCCGTTCACGAAGATGGCCTACAAGGCGCATCGCGCCCTGCTGAACTCCTGCGGGTACGACACCGACGAGGCGGAGGTCGCGCGCGCCATCGGGCGGACCACCGCCTACAACGCCGTCCTGGGCAACAGCTACACCGCGTCGGTGTACCTCGGCCTCGCCTCCCTGCTGGACGGGGCGGACGACCTGGCCGGACAGTGTGTCGGTCTCCTCAGCTACGGCTCCGGCAGCGTCGCCGAGTTCTTCGCCGGGACCGTGGCGCCCGGCTACCGCGACCACCTGCGGACCGCGGAGCACCGCGAGGCGATCGACCGGAGGAAGCCGGTCGGCTACGCCCGCTACCGCGAACTGCACGAGCGCTCCTTTCCGACCGACGGCGGCGACCACCCCACTCCTTCGGAGACCACCGGGCCGTTCCGGCTGGCCGCTCTCCGCGGCCACAAGCGCGTCTACGAAGTGCGCTGA	MAGETAVGIHDLSFATTEFVLPHTALADHNGTDIGKYHRGIGQRSMSVPAADEDIVTMGAAAAAPIIARHGFDRIRTVVLATESSVDQAKSAGVYVHSLLGLPSATRVVELKQACYGATAALQFAIGLVHRDPAQQVLVVASDISKYELDSPGEATQGAAAVAMLVGSDPALLRVEEPSGLFTADVMDFWRPNYRDAALVDGQESITAYLQAVEGTWKDYTERGGRALDAFSAFCYHQPFTKMAYKAHRALLNSCGYDTDEAEVARAIGRTTAYNAVLGNSYTASVYLGLASLLDGADDLAGQCVGLLSYGSGSVAEFFAGTVAPGYRDHLRTAEHREAIDRRKPVGYARYRELHERSFPTDGGDHPTPSETTGPFRLAALRGHKRVYEVR	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	72.14	gnl|BL_ORD_ID|2510|hsp_num:0	2904			489	630	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
BGC0001080.1|Phenazine_9 # 8640 # 9353 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0001080.1|Phenazine_9 	8640	9353	+	Loose	725	27.335	mdtA	34.21	3000792	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGACGATCGCACGTCCCTCGTCCACCCGGAGACGGACACCACCGTGAAGGTCGCCGTCATCTACCACTCCGCCACCGGCCATGTCGCGGACATCGCCCGCGAACTCTCCGATGCCGCCGAGAAGGCCGGTGCCGAGGTACGGCTGCGCAAGGTCGCGGAGCTCGAACCGCTGCGGTCCGTCGCCTCCCTGCCCGCCCGGGTGGCCAACGCCACGGCGACCGCTGACATATCCGTCGCCGCGGTGGGGGACGTCCTGTGGGCCGATGCCGTGCTGCTGGGGTCGCCGGCCCGGTTCGGGAACATCGCGGCCCAGCTCGCCCGGTTCATCGAGTCCTTGGGCGGAGCGTGGAAGAGGGGCGCGCTGGCCGACAAGATCTACAGCGGCTTCACCTCCACCGCGAGCGCCCACGGGGGCAACGAGGCGACCCTCCTCGCCCTCATGAACTCCTTCCACCACTTCGGTGGCATCGTCGTCACCCCCGGTTTCACCCATCCGGACAAGTTCGTCGACGGCAATCCGTACGGCACCGCGCACCATGACGGGAGCGGCACCCTCCCGGTCGGCGACGTCACACGGAACGCGGCCCGCGTGCAGGCCGAGCGCGTGGTGCGCCTGGCCGGGGTCCTGAGGGCCGCGTCCGTCCGCCCCACCGCCCACCGGCGCGCCGCGTCCCGTCTCAGCACCGGCGCCGCAGAGCGATCTGCGTGA	MKDDRTSLVHPETDTTVKVAVIYHSATGHVADIARELSDAAEKAGAEVRLRKVAELEPLRSVASLPARVANATATADISVAAVGDVLWADAVLLGSPARFGNIAAQLARFIESLGGAWKRGALADKIYSGFTSTASAHGGNEATLLALMNSFHHFGGIVVTPGFTHPDKFVDGNPYGTAHHDGSGTLPVGDVTRNAARVQAERVVRLAGVLRAASVRPTAHRRAASRLSTGAAERSA	MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSRSAAPGATKQAQQSPAGGRRGMRSGPLAPVQAATAVEQAVPRYLTGLGTITAANTVTVRSRVDGQLIALHFQEGQQVKAGDLLAEIDPSQFKVALAQAQGQLAKDKATLANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIKADEASVASAQLQLDWSRITAPVDGRVGLKQVDVGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVVQAQKAGKPLVVEAWDRTNSKKLSEGTLLSLDNQIDATTGTIKVKARFNNQDDALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWVLNSENKVSKHLVTPGIQDSQKVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKATSREYAKKGARS	57.11	gnl|BL_ORD_ID|353|hsp_num:0	387			975	1089	novobiocin
BGC0001080.1|Phenazine_10 # 9322 # 9504 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.689	BGC0001080.1|Phenazine_10 	9322	9504	-	Loose	600	21.9422	EstT	45.83	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGACCAGGCTGCCCCGCCACAGACTCGTGCCGACGAACGTGGCCGCCCTCGCGGCGGGCGTGTCCGAAGCGACCATCCGGAAGTGGGTGAGCCGCGGGAAGATCACGCGCTACGGCACTCCGGGCCGCTCGGAGTTCGACATAGAGGAACTCACGCAGATCGCTCTGCGGCGCCGGTGCTGA	MTRLPRHRLVPTNVAALAAGVSEATIRKWVSRGKITRYGTPGRSEFDIEELTQIALRRRC	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	19.61	gnl|BL_ORD_ID|4956|hsp_num:0	5948			258	327	tigecycline
BGC0001080.1|Phenazine_11 # 9501 # 10121 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.671	BGC0001080.1|Phenazine_11 	9501	10121	-	Loose	530	27.7202	OXA-290	21.67	3001745	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCACCCCACTCATGCCCCAGAAACCACACACGGGACATCGCGGCCGGTCCCGCTCTCTGCAAGCCCTGCGTCGGACAGCTGGAACACCAACTGCGCGCACTTCCCGGTCTCCACCAGGACTGCCTGCACCACGTGCTATCGACATCCCGGCGAAGGAATCCGACGAAAGTGTCCGGCAGCCGCAAGCGGGATCACCTCAACGTCGCCGCGCTCGACGCCCGCAACGACCTGATCCCGGTCCTGACCTCCTGGTCGGGACTGGTCGCCGAGAGGCTCGGGACCGTCGTACCGCATCGCTCCGTCGTCCACCTGGCGGACTTTCTCCTCCTCAATCTCGAGTGGCTCACCGCCCACCCCTCGGCCGCCGACTTCGCGGAGGAGATCGAGGACCTCCACACGGAACTGCTCCGTGCGATCGACCCCGATGCCGGTGATCGCCCGCCGCCCGCCACGGAGTGTGTCGTGGATGCCTGCACGGGGACGATCAACGCCTCGCCGAAGAGCACCGGAAAAGCCGGCACGAGGAGCATCAGCTGTTCCGCGGGGCATGCGTGGGAGATGCGCGAGTGGCTCACCCTGCGGTACCTCATGGATCGGCGACGGAAGGACGCCGCATGA	MAPHSCPRNHTRDIAAGPALCKPCVGQLEHQLRALPGLHQDCLHHVLSTSRRRNPTKVSGSRKRDHLNVAALDARNDLIPVLTSWSGLVAERLGTVVPHRSVVHLADFLLLNLEWLTAHPSAADFAEEIEDLHTELLRAIDPDAGDRPPPATECVVDACTGTINASPKSTGKAGTRSISCSAGHAWEMREWLTLRYLMDRRRKDAA	MIGLTLLGCQNLHAPTQSAVSKKHDQTEIASLFQHTQTVGVFVTYDGQTFQEYGNALSRSNTAYIPASTFKMLNALIGIQHHKSSPNEVFKWDGKKRAFASWEKDLTLAEAMQASAVPVYQELARRIGLELMANEVKRVGFGNTEIGTQVDDFWLVGPLKITPVDEVKFAYALANKQLAFDQSVQEQVKQMVFVDEVHGTKIYAKSGWGMDVTPQVGWWTGWIEQPNGQVIAFALNLEINKPEHGDARKAIVYQALQQLKLLQKQ	77.74	gnl|BL_ORD_ID|4756|hsp_num:0	5751			42	222	cloxacillin; oxacillin; cefalotin
BGC0001080.1|Phenazine_12 # 10210 # 11232 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0001080.1|Phenazine_12 	10210	11232	-	Loose	500	29.6462	chrB	46.67	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAGTACCGACATCGCACCCGGAGCAGCCCGCGCCACCCTCGATCTCGTCACCGCCGCCTGGCGGACCCAGTCCGTCTACGCGGCGGCCAAGCTGGGCCTGCCGGACCTCATCGCGGCAGGGCACACCGCGGCGCCGGACCTCGCCCGGGCAGCCGGCGCGGACGAGGACGCCGTGCAGCGCCTGCTGCGGCTGCTCGTACGCCTCGACGTGTTCACGTGGGACGAGGACGGCGGGTACGGCAACACCGAGGTGGGCGACCTGCTGCGGGACCGGCCCGGCTCGCTGCGCGACGTGTGCCTGCTGTACGGCGAGGAGTTCTACCAGGCGTGGGGGCACGCCATCGAGACGGCCCGCACCGGCAAACCCGGGTTCGAGGTGGCGTACGGACAGTCGCTCGTCTCCTACCTGCACGACGACGCCGATGCGGCGAACCGCTTCCAGCGGGTCATGCGGGCACAGGCGGACAACTTCGCCTTCGAAGCGGTCCCCCGGGAGATCGACTTCAGCGCCGACCGGCACGTCGTCGACATAGCCGGTGGCAGCGGCCAGCTGCTGTCCACCGTGCTGGCCACGGCACCCGGGGCCCGGGGCACCCTCCTCGACCTCGAACACACGATTCCCATCGCCCGCGCACACCTGGAGCGGACGGTGGGCTGCGACCGCGTCGGCCTGGTGGCCGGCGACATGTTCACCAGTCCCCTCCCCGGGGAGGCGGACACCTATCTGCTGTCCCGGGTCCTCGGCGACTGGCCGGACGACGACTGCGTACGTCTCCTGGGCAACGTACGCGAGGTCATGGCGAAGCACTCTCGGCTCGTGGTCATCGAGCTGGTCGTCCAGGACGGCCACGCCGGTCTGCTGGCTCCGCTGTGGGACCTGCACCTGATGGTCGTCAACGGCGGCCACCAGCGCTCCTTCGGCGAATACACCGAGCTGGCCGCACGCACCGGCCTCGCCGTCGAGCGGTCGGTACGCCTTCCGATGGAGGCCACGGCGCTGGTCCTGACCCCGGCCGGCTGA	MSTDIAPGAARATLDLVTAAWRTQSVYAAAKLGLPDLIAAGHTAAPDLARAAGADEDAVQRLLRLLVRLDVFTWDEDGGYGNTEVGDLLRDRPGSLRDVCLLYGEEFYQAWGHAIETARTGKPGFEVAYGQSLVSYLHDDADAANRFQRVMRAQADNFAFEAVPREIDFSADRHVVDIAGGSGQLLSTVLATAPGARGTLLDLEHTIPIARAHLERTVGCDRVGLVAGDMFTSPLPGEADTYLLSRVLGDWPDDDCVRLLGNVREVMAKHSRLVVIELVVQDGHAGLLAPLWDLHLMVVNGGHQRSFGEYTELAARTGLAVERSVRLPMEATALVLTPAG	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	121.43	gnl|BL_ORD_ID|274|hsp_num:0	305			276	366	tylosin; chalcomycin; mycinamicin
BGC0001080.1|Phenazine_13 # 11292 # 11798 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.679	BGC0001080.1|Phenazine_13 	11292	11798	-	Loose	450	26.1794	OXA-664	43.48	3004479	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCTCGCCGCTGCCCTCCGAACCCCACGCCGCCGCGCCGGTCTTCACCGACCACCACGACCTGCGGGAACGCAATCGACGAGCCGTCGAGCAGTACATGGTGACGGGCCCCGAGGCCCGGCTGAGCCGGTACACCCTCTACACCGAGGACGGCACCGCGTCCCTCTTCAACACCGACATCGGCCGGCCCATCACCGTCAAGGGCCGGGACAACCTGAAGCGGCACAACGAACTCTCCCTCGACGTACTCCCCGACTGGGAGTGGACCGACGTCCACCTCTACGAGACGCAGGACCCCGCCGTCATCTGGGTCGAGTGCGACGGCGAGGGCACGATCCGGTTCCCCGGCTATCCCGAGGGCCGCTACCGCAACCACTTCATCCACGGTTTCACGCTGCGCGACGGGCGGATCGCCGCCAGCCGCGAGTACACCAACCCGATCGAGCACATGCGCGCCCTCGGCATCGAGACGCCGAACATCGAGCGGGACTGGATCCCCTCCTGA	MTSPLPSEPHAAAPVFTDHHDLRERNRRAVEQYMVTGPEARLSRYTLYTEDGTASLFNTDIGRPITVKGRDNLKRHNELSLDVLPDWEWTDVHLYETQDPAVIWVECDGEGTIRFPGYPEGRYRNHFIHGFTLRDGRIAASREYTNPIEHMRALGIETPNIERDWIPS	MWMLKTISCSVLSWMLLSACSQQTLKDQMQQPLMMQQPRLAELNHMFQAVDSAVVFVTYDGEKLQRFGNDLHRAETAYIPASTFKILNALIGLQQHKTTTTEVFVWDGKARALKSWERDMTLAEAMQVSAVPVYQTLARRIGLPLMQKELHRVDYGNAQIGTQVDRFWLDGPLKITPQQEAEFAYRLATQTLPFDIHVQQEVKEMLYVERRGVAKLYAKSGWGADVKPQVG	72.73	gnl|BL_ORD_ID|2588|hsp_num:0	2909			132	201	cloxacillin; oxacillin; cefalotin
BGC0001080.1|Phenazine_14 # 11834 # 12535 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0001080.1|Phenazine_14 	11834	12535	-	Loose	500	26.1794	OXA-192	28.07	3001766	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCTGACCTGCCCCACGCCGACGGGATCTCCGACGGCGCCTCCGAGGGCCGCGAAGGCGCCGCCCGCTCCGAGTCGCTCACCGGTACCGACGAGGTGGACTTCCCCGAGTTCCTCGCGCCGCCCCCCGAGCCGCTGGGGCTGCTGGTCTCGTGGCTGGAGACCAGCAGCGCCCACGGGGTCCGGGAGGCGCGCGCCCTGGCCCTGGCCACGGCCGACGCCCGGGGCAGAAGCTCCTCCCGCATCGTGGTGCTCAACTCGGTGACCGAAGCGGGGATCGTCTTCGCCACCCACGCCGACAGCCGCAAGGGGCGGGAACTGGCCGAGAACCCCTGGGCTTCGGGCGTCCTGTACTGGCGGGAGACCAGCCAGCAGATCACGCTGGCGGGCCCCGTGTCCCGGCTGCCCGACGCCGAGGCGGAGGTCCTGTGGTCCGCACGGCCCCCCTTCACCCACGCCATGAGCACCGCCTCCCGGCAGAGCCGGCCCCTGGACGGCCTCGACCACGTCGCCCGGCTGCGGGCCACGGCCCGGGAACTAGGCGAACCGGAGCGGCCGCTGCCCCGCCCCTCGTCGTACGTGGTGTACCAACTCGCGCTCTCCTCGGTCGAGTTCTGGGCCAACGGCACGGACCGGCTGCACGAACGGCTCTGCTACGAACGCGCCGGCTGCGGCTGGACCATCACCAGGCTCCAGCCGTGA	MSDLPHADGISDGASEGREGAARSESLTGTDEVDFPEFLAPPPEPLGLLVSWLETSSAHGVREARALALATADARGRSSSRIVVLNSVTEAGIVFATHADSRKGRELAENPWASGVLYWRETSQQITLAGPVSRLPDAEAEVLWSARPPFTHAMSTASRQSRPLDGLDHVARLRATARELGEPERPLPRPSSYVVYQLALSSVEFWANGTDRLHERLCYERAGCGWTITRLQP	MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQVPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	86.62	gnl|BL_ORD_ID|1165|hsp_num:0	1269			573	702	cloxacillin; oxacillin; cefalotin
BGC0001080.1|Phenazine_15 # 12528 # 13367 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.693	BGC0001080.1|Phenazine_15 	12528	13367	-	Loose	1000	25.0238	MCR-5.2	28.3	3004698	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGCACAGCTATGTCGTCGTCGACGCGTTCGCGCGACGACCGCTCACCGGCAACCCCGTGGCGGTGTTCTTCGACAGTGACGACCTCGCCGCGGAGCAGATGCAGCGCATCGCGCGGGAGATGAACCTCTCGGAGACCACGTTCGTGCTCCGGCCCCGCCAGGACGGGGACGTACACGTGCGGATCTTCACCCCGGTCAACGAACTGCCTTTCGCCGGACACCCGTTACTCGGCACCGCCATCGCACTGGGCGGACGGACCGACGCGGACCGGTTGCGGATCGAGACGGCCATGGGGACCATCCCCTTCGAGCTGGAACGCGAGCACGGGGAGAAGGTCGTCGCGGCGAGCATGCGCCAGCCGGTCCCCGTGTGGGAACCGTTCGACCGCGCCGAGGAGCTCCTGGACGCACTGGGGGTGCGCGAGTCGACGCTGCCGGTGGAGATCTACCGCAACGGCCCCCGGCACGTCCTCGTCGGTTTCGAGAGCATCGAAGCCCTGTCGAAGGCCGACCCCGACCACCGGGCCTTGGCCGCGTTTCCGGACATGGCGACCAACTGCATAGCCGGTCACGGGAGTTCCTGGCGCAACCGGATGTTCTCGCCCGCGTACGGAGTGGTGGAGGACGCCGCGACCGGCTCCGCCGCCGGGCCCATCGCCATTCACCTCGCCCGGCACGGCCTCGCCGCGTACGGGCAGCGCGTCGAGATCACCCAGGGCGTCGAGATCGGCCGCCCCTCACCCATGAGGGCGCTCGTGCACGGCGAGGGCGACCGGGTCGACACCGTCGAAGTGTCGGGACACGGCGTCGTCTCCATCGAAGGAGTGCTGCATGTCTGA	MHSYVVVDAFARRPLTGNPVAVFFDSDDLAAEQMQRIAREMNLSETTFVLRPRQDGDVHVRIFTPVNELPFAGHPLLGTAIALGGRTDADRLRIETAMGTIPFELEREHGEKVVAASMRQPVPVWEPFDRAEELLDALGVRESTLPVEIYRNGPRHVLVGFESIEALSKADPDHRALAAFPDMATNCIAGHGSSWRNRMFSPAYGVVEDAATGSAAGPIAIHLARHGLAAYGQRVEITQGVEIGRPSPMRALVHGEGDRVDTVEVSGHGVVSIEGVLHV	MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTGLLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVREASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMDVLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQQGRRPRALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRDYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLDEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEALVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDEQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATCRKGQPQ	51.10	gnl|BL_ORD_ID|2313|hsp_num:0	3396			897	1056	colistin A; colistin B
BGC0001080.1|Phenazine_16 # 13464 # 15404 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0001080.1|Phenazine_16 	13464	15404	-	Loose	550	27.335	SHV-16	23.53	3001075	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGACGTACGGTCCGCGAGGAAACCCCGGCGCCCCCCGGGACCCCAGGCCCGGCGATCTGCTCGACCACGTGCTGCACACGGAGGGGGAGGCGTACGCCCTGCTGCACCGGCCCGGAGCGGCCGGGCGGGACGTCGTGGAAGTCCTGACCGGATCGGTGTCCCTGCCCGGCACGCTGGCCGACATCCCGCTGCCGCCGCGACCCGCCCCCGGAGCCGGCGCGCGCCACGAGGTGCTCGTCCTCGTCCCCTACCGGCAGCTCGCCGAGCGCGGCTTCGACTGCGCCGACGACGGGACGCCCCTGGTGGCGATGACGGTCACGGACACCCAACAGCTGCCGCTCGACGCGGCGTTGGCACGGCTTCCCGATGTGCCGACCCCGCTGGCCGGAGAGAGCTTCGACGTCGATGACGAGGCGTACGAGAACGTGGTGCGCCGCATCGTCAAGGAGATGATCGGTACCGGAGAGGGCGCGAACTTCGTCATCAAGCGCACCTTCGTCGCCGACATCACGGACTACGGGCCGCAGAGTGCCCCCGCGCTGTTCCGGCGGCTCCTCGAACGCGAGTCCGGCGCCCACTGGACGTTCCTGATCCACACGGGCACCCGGACCCTGGTCGGCGCCTCGCCCGAGCGGCACATCAGCCTCCAGGGCGGGACGGCCGTCATGAACCCCATCAGCGGCACGTACCGCTACCCGCCCTCGGGCCCCACCCTGTCGGGCGTGCTGGACTTCCTGAGCGACCGGAAGGAGACCGACGAGCTGTACATGGTCCTCGACGAGGAACTCAAGATGATGGCCCGGATCTGTGCGACGGGGGGCCGTGTGGTGGGCCCCTATCTCAAGGAGATGGCCAGGGTCGCGCACACCGAGTACTTCATCGAGGGACGCACGGACCGGGATGTGCGCGACATCCTGCGCGAGACGATGTTCGCCCCGACGGTCACCGGGAGCCCGCTGGAGAGCGCCTGCCGCATCATCCAGCAGTACGAGCCCGGCGGGCGTGGCTTCTACAGCGGCGCCGCCGTGCTCATCGGACGGGACGACGAAGGGGAGCGGGCCATGGACTCGGCCATCCTGATCCGCACCGCCGACATCAGCCGTGAGGGCCACATCGCCATCGGTGTCGGCGCCACCATCGTGCGGCACTCCGACCCGGCCTCCGAGGCCGCGGAGACCCGCGCCAAGGCGGCCGGACTCGTCGCCGCCCTCCGGGGAGACGAGAAGGAACGTTTCGCTCAGCATGCGAGCGTGCGCCGCGCACTGGAGCTCCGCAACGACTCCATCGCCGACTTCTGGTTGTCCGACGCCGAGGCGCGCGCGTCGGCGCTGCCCGGACTGGCCGGGCGCAGCGTCCTCGTCCTGGACGCCGAGGACACCTTCACGTCGATGATCGACCAGCAACTGCGGTCCCTGGGACTGCGGGTGACCGTCCGCCGGTACGACGAGCCGTACGCCTTCGAGGGGTACGACCTGGTCGTGATGGGGCCGGGCCCCGGGGATCCCCAGGAGGCCGCGCACCCCAAGATGCGGCACCTGCGCACGGCGGTCGGCACACTGCTGAGCCAACGTCGGCCCTTCCTCGCCGTCTGCCTCAGCCACCAGGTCCTCGGACTCCACATCGGGCTGCCGCTGCGCCGCAGGGCGGTGCCCAACCAAGGGGTGCAGAAGGACATCGACCTGTTCGGCGCCACCGAACGCGTCGGCTTCTACAACACCTTCGCCCTGGTCGGCGAGGACGACACGTTCGTCGCCGACGGAGTGGGGCCGGTCCGGGTCAGCCGGGACCCGGTCACCGGGGAGGTCCACGCGCTGCGCGGCCCGGGCTTCGCCTCCCTGCAGTTCCACCCCGAATCGGTACTCACCCGAGAAGGGCCCCGCATCGTGGGCACGGCACTGGGCGGTCTGCTCGCGCCGGCCCGCACGCCCGGCTCCGCCTGA	MTYGPRGNPGAPRDPRPGDLLDHVLHTEGEAYALLHRPGAAGRDVVEVLTGSVSLPGTLADIPLPPRPAPGAGARHEVLVLVPYRQLAERGFDCADDGTPLVAMTVTDTQQLPLDAALARLPDVPTPLAGESFDVDDEAYENVVRRIVKEMIGTGEGANFVIKRTFVADITDYGPQSAPALFRRLLERESGAHWTFLIHTGTRTLVGASPERHISLQGGTAVMNPISGTYRYPPSGPTLSGVLDFLSDRKETDELYMVLDEELKMMARICATGGRVVGPYLKEMARVAHTEYFIEGRTDRDVRDILRETMFAPTVTGSPLESACRIIQQYEPGGRGFYSGAAVLIGRDDEGERAMDSAILIRTADISREGHIAIGVGATIVRHSDPASEAAETRAKAAGLVAALRGDEKERFAQHASVRRALELRNDSIADFWLSDAEARASALPGLAGRSVLVLDAEDTFTSMIDQQLRSLGLRVTVRRYDEPYAFEGYDLVVMGPGPGDPQEAAHPKMRHLRTAVGTLLSQRRPFLAVCLSHQVLGLHIGLPLRRRAVPNQGVQKDIDLFGATERVGFYNTFALVGEDDTFVADGVGPVRVSRDPVTGEVHALRGPGFASLQFHPESVLTREGPRIVGTALGGLLAPARTPGSA	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKITHRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	221.99	gnl|BL_ORD_ID|1594|hsp_num:0	1739			474	864	
BGC0001080.1|Phenazine_18 # 16103 # 17281 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0001080.1|Phenazine_18 	16103	17281	-	Loose	575	27.335	CIA-2	45.45	3004769	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	CIA beta-lactamase	ATGGAAGACGTCATACGGGAGATTCGTATCCGCGGGGCATCACAGCAACCCGAGTGGAGCGATCTCCTACAGCTGAGCCGGGTGGCCGAGGCGCTCGGCGCACGCCCCACCCTCGTACAGGCCGACGATGTGGCGACGCTGCGCACTCTGCTGGGCAAGGTGGCGCTCGGAGAGGCCATGGTGCTGCAGTCCGGGGACTGCGCCGAGGACCCGCAGGAGTGCACACGTCCCCACGTGGCACGCAAGGCCGCGCTGCTCGACCTGCTCGCCGGGTCGCTCGGTCTGATCACCGGCAAGCCCGTCGTGAGGGCAGGACGTATCGCCGGGCAGTTCGCCAAGCCTCGTTCCAAGCCCACCGAATTCGTCGACGGCGTCGAACTTCCCGTCTTCCGCGGTCACATGGTCAACGGCCCCGAGCCGGACCGCGAGCGGCGGCAGGCCGACCCTCTTCGGATCCTCACCGGCTACATGGCCGCCCTCGACATCGTCGGACACATGGGCTGGCGCGACCGGGCCGAAGGGCGTGACGCCGTGGAGCCCCTGGTGTGGACCAGTCACGAGGCGCTCCTCCTCGACTACGAGATGCCCATGCTCCGCACGGACGCCAAGGGCCGGCTGTTCCTGGGTTCGACCCACTGGCCGTGGATCGGCGAGCGCACCCGCCAGGTCGAGGGCGCCCACGTCGCCCTGCTCGCCGAGGTGAGCAACCCGGTGGCGTGCAAGGTCGGCCCCTCCATGGAGCCGGACGAACTGCTCGCCCTGTGCGAGCGACTCGACCGGTGGCGCGACCCCGGGCGGCTCACTCTCATCGCGCGCATGGGAGCCGACGCCGTCGCCGACCGGCTGCCGCGCCTCGTCGAAGCCGTACGCGGCGCGGGCCACCCCGTCGTCTGGCTCAGCGACCCCATGCACGGCAACACCGTCACGGCGCCCGGCGGCCACAAGACGCGGCTCGTGGAGACGGTGTCGCTGGAGGTCACCCGCTTCGTCGAGGCCGTGCGCTCCGCGGGCGGTATCGCCGGCGGACTGCACCTGGAGACCACGCCGGACGACGTCACCGAGTGCGTCCTCGACGCGTCCGAGCTCGCCTCCGTCGGGGACCGCTACACCTCGCACTGCGATCCCCGTCTCACTCCGTCACAGGCGCTCTCCGTGGTCTCGGCCTGGACCGCCTCCTGA	MEDVIREIRIRGASQQPEWSDLLQLSRVAEALGARPTLVQADDVATLRTLLGKVALGEAMVLQSGDCAEDPQECTRPHVARKAALLDLLAGSLGLITGKPVVRAGRIAGQFAKPRSKPTEFVDGVELPVFRGHMVNGPEPDRERRQADPLRILTGYMAALDIVGHMGWRDRAEGRDAVEPLVWTSHEALLLDYEMPMLRTDAKGRLFLGSTHWPWIGERTRQVEGAHVALLAEVSNPVACKVGPSMEPDELLALCERLDRWRDPGRLTLIARMGADAVADRLPRLVEAVRGAGHPVVWLSDPMHGNTVTAPGGHKTRLVETVSLEVTRFVEAVRSAGGIAGGLHLETTPDDVTECVLDASELASVGDRYTSHCDPRLTPSQALSVVSAWTAS	MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPLLSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIITYTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTNATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKGTPVAHKTGSSGKPDNILAVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK	134.25	gnl|BL_ORD_ID|2557|hsp_num:0	3571			675	759	
BGC0001080.1|Phenazine_19 # 17316 # 17804 # -1 # ID=1_19;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.609	BGC0001080.1|Phenazine_19 	17316	17804	-	Loose	400	26.9498	QnrD2	32.35	3002789	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGCCTGATTCATTGCCGAACCAGGGATTCTCCGACGCGGCCGAACTGCGCCGGATCAACCGGGCCACCGTCGAGAAGTACATGCACACCAAGGGGCAGGACCGACTGCGTCGCCACGAGCTGTTCACCGAGGACGGCAGTGGTGGCCTGTGGACCACGGACACCGGCTCGCCGATCGCCACCCACGGCAAGGCGCGTCTCGCCGAACACGCTGTCTGGTCGCTGGAGTGCTTCCCCGACTGGGAATGGCACAACATCCGGATATTCGAGACCCAGGACCCCAATCACTTCTGGGTGGAGTGCGACGGGCGTGGGAAGATTCGCTTCGGTGACTACCCCGAGGGTTACTACGAGAACCACTTCCTCCACTCGTTCGAGCTCGAGAATGGGAAGATCAAGCAGAATCGTGAGTTCATGAACCCGTTCCAGCAACTGCGCGCGCTCGGCATTCCGGTGCCAGAAATCAAGCGCCAGGGAATACCCACCTGA	MPDSLPNQGFSDAAELRRINRATVEKYMHTKGQDRLRRHELFTEDGSGGLWTTDTGSPIATHGKARLAEHAVWSLECFPDWEWHNIRIFETQDPNHFWVECDGRGKIRFGDYPEGYYENHFLHSFELENGKIKQNREFMNPFQQLRALGIPVPEIKRQGIPT	MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR	75.70	gnl|BL_ORD_ID|475|hsp_num:0	517			177	279	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
